Search
Immunic Inc
IMUXAdd to Watchlist
6.970USD
-0.130-1.83%
Close 10-16 16:00（ET）
94.93MMarket Cap
LossP/E TTM
Immunic Inc (IMUX) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Immunic Inc in the past month.
Strong Buy
7 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
43.091USD+525.41%
IMUX Analyst Recommendation Trends
In the current month, IMUX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMUX average Analyst price target in the last month is 43.091.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
7
7
5
5
5
4
4
3
5
5
5
5
5
4
5
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
10
10
10
8
9
9
IMUX Analyst Rating for Peer Comparison
Updated: Oct 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Revolution Medicines Inc
RVMD
9
14
1
0
0
24
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
7
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
Based on analysts' estimates, IMUX EPS is projected to reach -0.946 in FY2026Q3, following reported EPS of -0.802 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.94
-0.91
-1.19
-0.95
-0.80
Actual
-0.99
-10.81
-0.80
--
--
Surprise
-5.51%
-1085.04%
+32.81%
--
--
FAQs
What is Immunic Inc's price target?
Analysts forecast that Immunic Inc's price target is USD 43.09, with the highest forecast at USD 85.00 and the lowest forecast at USD 22.00.
How have Immunic IncIMUX's recent earnings per share performed?
The market expectation was USD -0.80, while Immunic IncIMUX's earnings per share (EPS) for the previous quarter was USD -10.81. EPS for the next quarter is expected at USD -0.95.
What is the analyst rating for Immunic Inc?
Based on the ratings of Immunic Inc's stock from 12 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.